Dr. Oliver Peoples

CEO at Yield10 and 3 other companies
On the record
Represented by:
Recent Quotes
Sign up to view all
  • While we look forward to additional patents being granted on our inventions in 2019 and beyond, we continue to protect our discoveries with new filings. In 2019 alone, we have filed new patent applications related to our GRAIN technology platform as well as the use of our Camelina platform to cost-effectively produce PHA/PHB biomaterials. The growth of our intellectual property portfolio is a direct reflection of the innovative capabilities of our team.

    11 January 2020
Sign up to view all